PDA Letters (Cards)

Making Connections to Last a Lifetime

Shannon Sperati, PDA, Inc.

We're Going to New Orleans! Let’s Talk about Contamination Control and the Annex 1 Revision

Justin Johnson

Let the Good Times Roll in New Orleans!

PDA, Inc.

On The Issue: Philippe Germanaud

PDA, Inc.

Learning from the Past in A Patient-Centric World

Jason Kerr

Key Takeaways from the 2022 PDA Annex 1 Workshop in Dublin

Eilish Kelly and Patrick Nieuwenhuizen, PharmaLex

Joint Regulatory Conference: Bringing Better Innovation and Communication Moving Forward

Londa Ritchey, PharmaLex

Upcoming CCS Workshop — A New Direction in Workshop Design

Glenn Wright, PDA, Inc.

President’s Message: A Bittersweet Farewell

Richard Johnson, PDA

The Complex Process for Sterile Filling and Points to Consider

Mauro Giusti, Eli Lilly Italia, and Rebecca Brewer, QxP

ATMPs and Annex 1: Some Answers, but More Questions

Rebecca Brewer, Quality Executive Partners, and Richard Denk, SKAN on behalf of the PDA Advanced Therapeutics Medicinal Products Advisory Board

Hello PDA! A Formal Introduction to the PDA Letter

Justin Johnson, Editor

Are You Ready for Sustainable Packaging?

Bettine Boltres, PhD, WEST, and Derek Duncan, PhD, LIGHTHOUSE Instruments

Chair’s Message: A New Horizon for Our PDA Members around the World

Susan Schniepp, PDA Chair 2022-2023

Putting AI to the Test with Continued Process Verification

Marilyn L. Foster and Josh Eaton, PDA, Inc.

Modernizing Risk Assessment for Legacy Products

Sanjay Rajpal Sharma, Lupin

Spotlight on PDA Education in India

Biny Joseph, PDA India Chapter, Eduoriens Skill Development, and David Talmage, PDA, Inc.

Turning Annual Product Quality Reviews into a Strategic Advantage

Sofia Lange, Veeva Systems

PDA SoCal Chapter Two-Year Update

Stephanie Lee, Amgen Inc.

On The Issue: Next Gen ATMP Production

PDA, Inc.